Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Chartwell Pharmaceuticals LLC
EIR
•Chartwell Pharmaceuticals LLC•September 26, 2018

Chartwell Pharmaceuticals LLC – FDA EIR, Sep 26, 2018

Record Details

An FDA inspection of Chartwell Pharmaceuticals, LLC, located in Congers, NY, was conducted from September 12 to September 26, 2018. The inspection, performed under the Drug Manufacturing Inspection compliance program, focused on the company's Quality System, Facilities and Equipment, and Laboratory Control System. The inspection revealed several issues related to Current Good Manufacturing Practices. The main violations included a lack of established written procedures for equipment cleaning and maintenance, specifically failing to conduct protocol-driven cleaning validation studies for manufacturing equipment. Additionally, the firm lacked complete temperature mapping studies for its Finished Goods/Raw Material Warehouse, indicating insufficient procedures for drug product warehousing. There were also no written procedures for performing laboratory instrument audit trail reviews, which compromised electronic record reliability and data integrity. Lastly, the facility's raw material and finished goods warehouse had inadequate space, leading to potential mix-ups and cross-contamination. Company management acknowledged these observations and committed to implementing corrective actions, promising to submit a formal response to the FDA within 15 business days following the inspection.

Company
Chartwell Pharmaceuticals LLC
Inspection date
September 26, 2018
Product type
drugs
Office
Division of Pharmaceutical Quality Operations I
Person
  • Sony Mathews (Consumer Safety Officer Drug Specialist)
View Company Profile

ID · febb7431-dc16-4582-9cac-14e565fe0c46

Violation Codes6
21 CFR 211.68(a)21 CFR 820.19821 CFR 211.42(b)21 CFR 820.5021 CFR 211.14221 CFR 211.67(b)

Full citation text and observation details available on the Dashboard.

Other documents for Chartwell Pharmaceuticals LLC
  • 483 - 2024-12-19December 19, 2024
  • 483 - 2024-05-31May 31, 2024
  • 483 - 2023-05-24May 24, 2023
  • 483 - 2018-09-26September 26, 2018
  • EIR - 2016-11-01November 1, 2016

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Chartwell Pharmaceuticals LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.